Bibliografia Curcuma Antitumorale

La seguente bibliografie è relativa all’articolo “Curcuma Antitumorale Naturale“.

Cancro colon-rettale

1. Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, Berry DP, Hemingway D, Miller AS, Brown K, Gescher AJ, Steward WP.
   Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration–a clinical pilot study including assessment of patient acceptability.
   Cancer Prev Res (Phila). 2013 Feb;6(2):119-28.[PubMed]
2. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP.Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
   Clin Cancer Res. 2001 Jul;7(7):1894-900.[PubMed]
3. Bar-Sela G, Epelbaum R, Schaffer M.
   Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
   Curr Med Chem. 2010;17(3):190-7.[PubMed]
4. Ramamoorthi G, Sivalingam N.
   Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy.
   Tumour Biol. 2014 Aug;35(8):7295-305. doi: 10.1007/s13277-014-1840-1. Epub 2014 Mar 26. Review.[PubMed]
5. Goel A, Aggarwal BB.
   Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.
   Nutr Cancer. 2010;62(7):919-30. doi: 10.1080/01635581.2010.509835. [PubMed]
6. Bar-Sela G, Epelbaum R, Schaffer M.
   Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
   Curr Med Chem. 2010;17(3):190-7. Review[PubMed]
7. Patel BB, Majumdar AP.
   Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.
   Nutr Cancer. 2009;61(6):842-6. doi: 10.1080/01635580903285106. Review.[PubMed]
8. Reddy BS.
   Strategies for colon cancer prevention: combination of chemopreventive agents.
   Subcell Biochem. 2007;42:213-25. Review[PubMed]
9. Surh YJ, Chun KS.
   Cancer chemopreventive effects of curcumin.
   Adv Exp Med Biol. 2007;595:149-72. Review[PubMed]
10. Narayan S.
    Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways.
    J Mol Histol. 2004 Mar;35(3):301-7. Review[PubMed]
11. Chauhan DP.
    Chemotherapeutic potential of curcumin for colorectal Curr Pharm Des. 2002;8(19):1695-706. Review[PubMed]
12. Lin JK, Lin-Shiau SY.
    Mechanisms of cancer chemoprevention by curcumin.
    Proc Natl Sci Counc Repub China B. 2001 Apr;25(2):59-66.[PubMed]

Cancro del Pancreas

13.  Hariharan D, Saied A, Kocher HM.
    Analysis of mortality rates for pancreatic cancer across the world.
    HPB (Oxford). 2008;10(1):58-62.[PubMed]
14.  Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S.
    A pilot study of the antioxidant effect of curcumin in tropical pancreatitis.
    Indian J Med Res. 2005 Oct;122(4):315-8.[PubMed]
15.  Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al.
    Phase II trial of curcumin in patients with advanced pancreatic cancer.
    Clin Cancer Res. 2008;14(14):4491–4499[PubMed]
16.  Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, et al.
    A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer.  Cancer Chemother Pharmacol. 2011;68(1):157–164.[PubMed]
17.  Lev-Ari S, Zinger H, Kazanov D, Yona D, Ben-Yosef R, Starr A, Figer A, Arber N.
    Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Biomed Pharmacother. 2005 Oct;59 Suppl 2:S276-80.[PubMed]
18.  Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.
    Bimonte S, Barbieri A, Palma G, Luciano A, Rea D, Arra C.
    Biomed Res Int. 2013;2013:810423[PubMed]

Cancro al seno

19.  Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, et al.
    Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.
    Cancer Biol Ther.  2010;9(1):8–14.[PubMed]
20. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.
    Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR.
    Radiat Res. 2013 Jul;180(1):34-43.[PubMed]
21. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.
    Sinha D, Biswas J, Sung B, Aggarwal BB, Bishayee A.
    Curr Drug Targets. 2012 Dec;13(14):1799-819.[PubMed]
22. The impact of curcumin on breast cancer.
    Nagaraju GP, Aliya S, Zafar SF, Basha R, Diaz R, El-Rayes BF.
    Integr Biol (Camb). 2012 Sep;4(9):996-1007.[PubMed]
23. Curcumin Reduces Cytotoxicity of 5-Fluorouracil Treatment in Human Breast Cancer Cells.
    Ferguson JE, Orlando RA.
    J Med Food. 2014 Jan 29.[PubMed]
24. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo.
    Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN, Wang HB, Kong B.
    Int J Clin Exp Pathol. 2014 May 15;7(6):2818-24. eCollection 2014.[PubMed]
25. Curcumin in chemoprevention of breast cancer.
    Terlikowska K, Witkowska A, Terlikowski S.
    Postepy Hig Med Dosw (Online). 2014 Jan 2;68:571-8.[PubMed
26. Shao ZM1, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M
    Curcumin exerts multiple suppressive effects on human breast carcinoma cells.
    Int J Cancer. 2002 Mar 10;98(2):234-40.[PubMed]

Cancro alla prostata

27. Ide H, Tokiwa S, Sakamaki K, Nishio K, Isotani S, Muto S, et al.
    Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen
    Prostate. 2010;70(10):1127–1133.[PubMed]
28. Cimino S, Sortino G, Favilla V, Castelli T, Madonia M, Sansalone S, Russo GI, Morgia G.Polyphenols: key issues involved in chemoprevention of prostate cancer.
    Oxid Med Cell Longev. 2012;2012:632959 [PubMed]
29. Cabrespine-Faugeras A, Bayet-Robert M, Bay JO, Chollet P, Barthomeuf C.
    Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.
    Nutr Cancer. 2010;62(2):148-53.[PubMed]

Mieloma Multiplo e Gammopatia Monoclonale

30. Kyle RA, Rajkumar SV.
    Monoclonal gammopathy of undetermined significance.
    Clin Lymphoma Myeloma. 2005;6(2):102–114.[PubMed]
31. Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R.
    The potential role of curcumin in patients with monoclonal gammopathy of undefined significance–its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.
    Clin Cancer Res. 2009;15(18):5917–5922.[PubMed]
32. Vadhan-Raj S, Weber D, Wang M, Giralt S, Alexanian R, Thomas S, et al.
    Curcumin downregulates NF-КB and related genes in patients with multiple myeloma: results of a phase 1/2 study.
    Blood. 2007;110(11):357a

Cancro al polmone

33. Polasa K, Raghuram TC, Krishna TP, Krishnaswamy K.
    Effect of turmeric on urinary mutagens in smokers.
    Mutagenesis. 1992;7(2):107–109.[PubMed]
34. Lu Y, Wei C, Xi Z
    Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway.
    In Vitro Cell Dev Biol Anim. 2014 Oct;50(9):840-50.[PubMed]
35. Howells LM, Mahale J, Sale S, McVeigh L, Steward WP, Thomas A, Brown K.
    Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies.
    J Pharmacol Exp Ther. 2014 Sep;350(3):483-94.[PubMed]
36. Chen P, Li J, Jiang HG, Lan T, Chen YC.
    Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Tumour Biol. 2014 Dec 27.[PubMed]
37. Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ, Lv GY.
    Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
    J Nutr Biochem. 2014 Feb;25(2):177-85.[PubMed]
38. Mehta HJ, Patel V, Sadikot RT.
    Curcumin and lung cancer-a review.
    Target Oncol. 2014 Dec;9(4):295-3

Cancro della pelle

39. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY.
    Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
    Anticancer Res. 2001 Jul-Aug;21(4B):2895-900[PubMed]
40. Curcumin: a novel treatment for skin-related disorders.
    Nguyen TA, Friedman AJ.
    J Drugs Dermatol. 2013 Oct;12(10):1131-7.[PubMed]
41. Chemoprevention of skin melanoma: facts and myths.
    Uzarska M, Czajkowski R, Schwartz RA, Bajek A, Zegarska B, Drewa T.
    Melanoma Res. 2013 Dec;23(6):426-33.[PubMed]
42. Beneficial role of curcumin in skin diseases.
    Thangapazham RL, Sharma A, Maheshwari RK.
    Adv Exp Med Biol. 2007;595:343-57.[PubMed]
43. A systematic review of topical treatments to control the odor of malignant fungating wounds.
    da Costa Santos CM, de Mattos Pimenta CA, Nobre MR.
    J Pain Symptom Manage. 2010 Jun;39(6):1065-76[PubMed]
44. Thangapazham RL, Sharma A, Maheshwari RK.
    Beneficial role of curcumin in skin diseases.
    Adv Exp Med Biol. 2007;595:343-57.[PubMed]
45. Ahmad N, Katiyar SK, Mukhtar H.
    Antioxidants in chemoprevention of skin cancer.
    Curr Probl Dermatol. 2001;29:128-39. Review.